What's new for people with ATM, CHEK2 or PALB2 mutations?

Learn about the cancer risks associated with an ATM, CHEK2 or PALB2 mutation and the risk-management options for people with an inherited mutation in one of these genes. Presented by Tuya Pal, MD; Marc Tischkowitz, MD, PhD. Learn more about genetic testing and hereditary cancer:
Our mission is to improve the lives of individuals and families facing hereditary cancer.
Sign up to stay in-the-know about hereditary cancer www.facingourrisk.org/subscribe
FORCE website
/ facingourrisk
FORCE on Facebook  FORCE: Facing Our Risk of Cancer Empowered / facingourrisk
FORCE on Instagram facingourrisk
www.linkedin.com/company/forc...
FORCE on LinkedIn  FORCE: Facing Our Risk of Cancer Empowered
www.linkedin.com/company/forc...
FORCE on Twitter  @FacingOurRisk
FacingOurRisk?ref...